UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overnight switch from rasagiline to safinamide in Parkinson's disease patients with motor fluctuations: a tolerability and safety study

European journal of neurology, 2021-01, Vol.28 (1), p.349-354

2021

Volltextzugriff (PDF)

Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry

Nutrition, metabolism, and cardiovascular diseases, 2014-12, Vol.24 (12), p.1346-1353

2014

Volltextzugriff (PDF)

Three years of experience: the Italian registry and safety data update

Neurological sciences, 2011, Vol.31 (Suppl 3), p.295-297

2011

Volltextzugriff (PDF)

PCN99 ITALIAN MONITORING REGISTRY OF BEVACIZUMAB IN THE TREATMENT OF METASTATIC COLON RECTAL CARCINOMA

Value in health, 2011, Vol.14 (3), p.A172-A172

2011

Volltextzugriff (PDF)

Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

Recent patents on anti-cancer drug discovery, 2019-01, Vol.14 (1), p.39-52

2019

Volltextzugriff (PDF)

Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

The New England journal of medicine, 2003-12, Vol.349 (24), p.2293-2303

2003

Volltextzugriff (PDF)

Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

The New England journal of medicine, 2003-12, Vol.349 (24), p.2304-2315

2003

Volltextzugriff (PDF)

HIV‐related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/µL): an analysis of 338 clinical events from a randomized clinical trial

HIV medicine, 2002-04, Vol.3 (2), p.75-84

2002

Volltextzugriff (PDF)

Hemochromatosis Gene Polymorphisms, Mitochondrial Haplogroups, and Peripheral Lipoatrophy during Antiretroviral Therapy

The Journal of infectious diseases, 2008-03, Vol.197 (6), p.858-866

2008

Volltextzugriff (PDF)

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment

Antiviral research, 2000-09, Vol.47 (3), p.189-198

2000

Volltextzugriff (PDF)

Smoking habits of italian athletes undergoing anti-doping control

Drug testing and analysis, 2016-01, Vol.8 (1), p.133-135

2016

Volltextzugriff (PDF)

European Clinical Trials Directive: the Italian position

The Lancet (British edition), 2004-05, Vol.363 (9421), p.1651-1652

2004

Volltextzugriff (PDF)

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection

AIDS research and human retroviruses, 2000-11, Vol.16 (17), p.1809-1820

2000

Volltextzugriff (PDF)

Role of a research ethics committee in follow-up and publication of results

The Lancet (British edition), 2003-06, Vol.361 (9376), p.2246-2246

2003

Volltextzugriff (PDF)

A Randomized Trial (ISS 902) of Didanosine versus Zidovudine in Previously Untreated Patients with Mildly Symptomatic Human Immunodeficiency Virus Infection

The Journal of infectious diseases, 1997-02, Vol.175 (2), p.255-264

1997

Volltextzugriff (PDF)

Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients

AIDS research and human retroviruses, 1995-10, Vol.11 (10), p.1203-1207

1995

Volltextzugriff (PDF)

Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults

AIDS (London), 1998-03, Vol.12 (5), p.473-480

1998

Volltextzugriff (PDF)

Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients

AIDS (London), 2000-11, Vol.14 (16), p.2567-2574

2000

Volltextzugriff (PDF)

Effect of sex, age, and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients

AIDS (London), 1995, Vol.9 (1), p.51-56

1995

Volltextzugriff (PDF)

Risk factors and occurrence of rash in HIV‐positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside‐experienced patients with very low CD4 levels (<50 cells/mμL)

HIV medicine, 2004-01, Vol.5 (1), p.1-10

2004

Volltextzugriff (PDF)

AIDS-defining events in patients starting protease inhibitors (PI) in very advanced HIV disease (below 50 CD4/mm super(3)): an analysis of 338 clinical events from a randomized clinical trial

AIDS (London), 2000-10, Vol.14, p.S128-S128

2000

Volltextzugriff (PDF)

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4 < 50/mm3)

HIV clinical trials, 2000-10, Vol.1 (2), p.9-16

2000

Volltextzugriff (PDF)

Survival of Zidovudine-Treated Patients With AIDS Compared With That of Contemporary Untreated Patients

JAMA : the journal of the American Medical Association, 1992-03, Vol.267 (9), p.1232

Vella, Stefano

1992

Volltextzugriff (PDF)

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment1

Antiviral research, 2000-09, Vol.47 (3), p.189-198

2000

Volltextzugriff (PDF)

A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease

Journal of acquired immune deficiency syndromes and human retrovirology, 1999-01, Vol.20 (1), p.11-19

1999

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(123)
Bücher
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(87)
Science & Technology
(87)
Humans
(74)
Male
(47)
Female
(44)
Adult
(41)
Urology & Nephrology
(38)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Middle Aged
(35)
Immunology
(21)
Aged
(20)
Nephrology. Urinary Tract Diseases
(19)
Animals
(17)
Iga Nephropathy
(16)
Nephropathies. Renovascular Diseases. Renal Failure
(16)
Glomerulonephritis
(13)
Hiv Infections - Drug Therapy
(13)
Aids/hiv
(12)
Infectious Diseases
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overnight switch from rasagiline to safinamide in Parkinson's disease patients with motor fluctuations: a tolerability and safety study

Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry

Three years of experience: the Italian registry and safety data update

PCN99 ITALIAN MONITORING REGISTRY OF BEVACIZUMAB IN THE TREATMENT OF METASTATIC COLON RECTAL CARCINOMA

Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

HIV‐related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/µL): an analysis of 338 clinical events from a randomized clinical trial

Hemochromatosis Gene Polymorphisms, Mitochondrial Haplogroups, and Peripheral Lipoatrophy during Antiretroviral Therapy

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment

Smoking habits of italian athletes undergoing anti-doping control

European Clinical Trials Directive: the Italian position

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection

Role of a research ethics committee in follow-up and publication of results

A Randomized Trial (ISS 902) of Didanosine versus Zidovudine in Previously Untreated Patients with Mildly Symptomatic Human Immunodeficiency Virus Infection

Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients

Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults

Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients

Effect of sex, age, and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients

Risk factors and occurrence of rash in HIV‐positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside‐experienced patients with very low CD4 levels (<50 cells/mμL)

AIDS-defining events in patients starting protease inhibitors (PI) in very advanced HIV disease (below 50 CD4/mm super(3)): an analysis of 338 clinical events from a randomized clinical trial

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4 < 50/mm3)

Survival of Zidovudine-Treated Patients With AIDS Compared With That of Contemporary Untreated Patients

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment1

A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease

Suchergebnisse filtern